Three barriers to innovative diagnostics

被引：10

作者：

Billings, Paul R. ^{[1
]}

机构：

[1] Lab Corp Amer Holdings, Corp Dev, Burlington, NC 27215 USA

来源：

NATURE BIOTECHNOLOGY | 2006年 / 24卷 / 08期

关键词：

D O I：

10.1038/nbt0806-917

中图分类号：

Q81 [生物工程学（生物技术）]; Q93 [微生物学];

学科分类号：

071005 ; 0836 ; 090102 ; 100705 ;

摘要：

Although technology adoption and remuneration are significant barriers to the development and implementation of innovative diagnostics, health imperialism may be just as important.

引用

页码：917 / 918

页数：2

共 4 条

[1]

[Anonymous], 2005, VAL DIAGN INN AD DIF

[2] Genetic nondiscrimination [J].

Billings P.R. .

Nature Genetics, 2005, 37 (6) :559-560

[3] Using pharmacogenetics to improve drug safety and efficacy [J].

Haga, SB ;

Burke, W .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2004, 291 (23) :2869-2871

[4] Interobserver reproducibility of cervical cytologic and histologic interpretations - Realistic estimates from the ASCUS-LSIL triage study [J].

Stoler, MH ;

Schiffman, M .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 285 (11) :1500-1505

← 1 →